Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-18

Clinical Trial Update: Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide [NA]

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating initiation of androgen deprivation therapy for prostate cancer using degarelix followed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Firmagon (Degarelix)
  • Lupron (leuprolide)

Snippet

Sponsor: Urology of Virginia | Conditions: Prostate Cancer | NA | Status: COMPLETED